Background: Conservative management may be a desirable option for elderly, fragile, or demented patients who reach end-stage renal disease (ESRD), yet some patients with dementia are placed on renal replacement therapy nonetheless. Methods: From a nationwide cohort of 45,076 US veterans who transitioned to ESRD over 4 contemporary years (October 1, 2007 to September 30, 2011), we identified 1,336 (3.0%) patients with International Classification of Diseases, Ninth Revision, Clinical Modification code-based dementia diagnosis during the prelude (predialysis) period. We examined the association of prelude dementia with all-cause mortality within the first 6 months following transition to dialysis, using a propensity-matched cohort and Cox proportional hazards models. Results: In the entire cohort, the overall mean ± standard deviation age at baseline was 72 ± 11 years, 95% were male, 23% were African-American, and 66% were diabetic. There were 8,080 (18.5%) deaths (mortality rate, 412; 95% confidence interval [CI], 403-421/1,000 patient-years) in the dementia-negative group, and 396 (29.6%) deaths (mortality rate, 708; 95% CI, 642-782/1,000 patient-years) in the dementia-positive group in the entire cohort in the first 6 months after dialysis initiation. Presence of dementia was associated with higher risk of all-cause mortality (adjusted hazard ratio, 1.25; 95% CI, 1.12-1.38) compared to dementia-free patients in the first 6 months after dialysis initiation. Conclusion: Pre-ESRD dementia is associated with increased risk of early post-ESRD mortality in veterans transitioning to dialysis.

Keywords:
End-stage renal disease, Transition, End of life care, dementia, Mortality, Chronic kidney disease
1.
Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O'Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC: US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2015;66(1 suppl 1):Svii, S1-S305.
2.
Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA: US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2016;67(3 suppl 1):Svii, S1-S305.
3.
Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007;2:89-99.
4.
Soucie JM, McClellan WM: Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 1996;7:2169-2175.
5.
Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, Soohoo M, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP: Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant 2016, Epub ahead of print.
6.
Jassal SV, Karaboyas A, Comment LA, Bieber BA, Morgenstern H, Sen A, Gillespie BW, De Sequera P, Marshall MR, Fukuhara S, Robinson BM, Pisoni RL, Tentori F: Functional dependence and mortality in the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2016;67:283-292.
7.
Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP: Association of slopes of estimated glomerular filtration rate with post-end-stage renal disease mortality in patients with advanced chronic kidney disease transitioning to dialysis. Mayo Clin Proc 2016;91:196-207.
8.
Molnar MZ, Gosmanova EO, Sumida K, Potukuchi PK, Lu JL, Jing J, Ravel VA, Soohoo M, Rhee CM, Streja E, Kalantar-Zadeh K, Kovesdy CP: Predialysis cardiovascular disease medication adherence and mortality after transition to dialysis. Am J Kidney Dis 2016;68:609-618.
9.
Grubbs V, Moss AH, Cohen LM, Fischer MJ, Germain MJ, Jassal SV, Perl J, Weiner DE, Mehrotra R; Dialysis Advisory Group of the American Society of Nephrology: A palliative approach to dialysis care: a patient-centered transition to the end of life. Clin J Am Soc Nephrol 2014;9:2203-2209.
10.
Ying I, Levitt Z, Jassal SV: Should an elderly patient with stage V CKD and dementia be started on dialysis? Clin J Am Soc Nephrol 2014;9:971-977.
11.
Helvik AS, Engedal K, Benth JS, Selbaek G: Prevalence and severity of dementia in nursing home residents. Dement Geriatr Cogn Disord 2015;40:166-177.
12.
Raphael KL, Wei G, Greene T, Baird BC, Beddhu S: Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol 2012;35:49-57.
13.
Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL: Cognitive impairment in hemodialysis patients is common. Neurology 2006;67:216-223.
14.
Kurella M, Mapes DL, Port FK, Chertow GM: Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2006;21:2543-2548.
15.
Rakowski DA, Caillard S, Agodoa LY, Abbott KC: Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol 2006;1:1000-1005.
16.
United States Renal Data System, 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014.
17.
US Department of Veterans Affairs: VIReC Research User Guide; VHA Medical SAS Inpatient Datasets FY2006-2007. Hines, IL, VA Information Resource Center, 2007.
18.
VA Information Resource Center: VIReC Research User Guide: VHA Pharmacy Prescription Data, ed 2. Hines, IL, US Department of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center, 2008.
19.
Kovesdy CP, Norris KC, Boulware LE, Lu JL, Ma JZ, Streja E, Molnar MZ, Kalantar-Zadeh K: Association of race with mortality and cardiovascular events in a large cohort of US veterans. Circulation 2015;132:1538-1548.
20.
Kovesdy CP, Alrifai A, Gosmanova EO, Lu JL, Canada RB, Wall BM, Hung AM, Molnar MZ, Kalantar-Zadeh K: Age and outcomes associated with BP in patients with incident CKD. Clin J Am Soc Nephrol 2016;11:821-831.
21.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
22.
Garcia-Ptacek S, Farahmand B, Kareholt I, Religa D, Cuadrado ML, Eriksdotter M: Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. J Alzheimers Dis 2014;41:467-477.
23.
Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP: Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis 2010;56:693-703.
24.
Maravic M, Ostertag A, Urena P, Cohen-Solal M: Dementia is a major risk factor for hip fractures in patients with chronic kidney disease. Osteoporos Int 2016;27:1665-1669.
25.
Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S: Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC Geriatr 2016;16:204.
26.
Lara E, Koyanagi A, Domenech-Abella J, Miret M, Ayuso-Mateos JL, Haro JM: The impact of depression on the development of mild cognitive impairment over 3 years of follow-up: a population-based study. Dement Geriatr Cogn Disord 2017;43:155-169.
27.
Chakrabarty T, Sepehry AA, Jacova C, Hsiung GY: The prevalence of depressive symptoms in frontotemporal dementia: a meta-analysis. Dement Geriatr Cogn Disord 2015;39:257-271.
28.
Frahm-Falkenberg S, Ibsen R, Kjellberg J, Jennum P: Health, social and economic consequences of dementias: a comparative national cohort study. Eur J Neurol 2016;23:1400-1407.
29.
van de Vorst IE, Koek HL, Stein CE, Bots ML, Vaartjes I: Socioeconomic disparities and mortality after a diagnosis of dementia: results from a nationwide registry linkage study. Am J Epidemiol 2016;184:219-226.
30.
Aihara Y, Kato H, Sugiyama T, Ishi K, Goto Y: Public attitudes towards people living with dementia: a cross-sectional study in urban Japan (innovative practice). Dementia (London) 2016, Epub ahead of print.
31.
Picco L, Abdin E, Pang S, Vaingankar JA, Jeyagurunathan A, Chong SA, Subramaniam M: Association between recognition and help-seeking preferences and stigma towards people with mental illness. Epidemiol Psychiatr Sci 2016, Epub ahead of print.
32.
Renal Physicians Association: Shared decision-making in the appropriate initiation of and withdrawal from dialysis: clinical practice guideline. Rockville, MD, Renal Physicians Association, 2010.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.